Similar Items: CAMK1D as a potential therapeutic target for gut microbiota-driven promotion of lung adenocarcinoma development
- Gut microbiota dysbiosis and the gut–lung axis: links to asthma and its common comorbidities
- The role of gut microbiota in Hirschsprung’s disease: from pathogenic mechanisms to microbiota-targeted therapies
- Spotlights on ubiquitin-specific proteases in lung cancer: from multifaceted pathophysiological mechanisms to potential therapeutic targets
- PLK1 overexpression as a dual-role biomarker and therapeutic vulnerability in pulmonary adenocarcinoma
- Human landscape disturbance and wildlife gut microbiota: global knowledge gaps
- Seasonality shapes gut microbiota composition in two sympatric sea urchins